BioSpace News Archive

Drug Development

SanBio Announces Phase 2 STEMTRA Trial Using SB623 Cells for Treatment of Patients with Traumatic Brain Injury Met Primary Endpoint

The SanBio Group announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury (TBI), met its primary endpoint.

November 1, 2018
·
1 min read
Business

Cresco Labs Celebrates Pilot Harvest And Flagship Cannabis Product Rollout In California

Products from Initial Harvest Feature Premium

November 1, 2018
·
2 min read
Business

ERS Genomics Licenses CRISPR Gene Editing Technology to DefiniGEN to Develop Human Cell Models to Support the Preclinical Development of Therapeutics

ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents.

November 1, 2018
·
2 min read
Business

OsteoRemedies® Announces the First FDA Cleared Dual-Antibiotic Spacer and Bone Cement with Gentamicin and Vancomycin

OsteoRemedies®, LLC is pleased to announce the launch of the REMEDY SPECTRUM™️ GV Hip Spacer System and SPECTRUM™️ GV Bone Cement.

November 1, 2018
·
2 min read
Job Trends

Approximately 1 in 3 Adults with Diabetes May Develop Chronic Kidney Disease

DaVita raises awareness about link between diabetes and CKD during National Diabetes Awareness Month

November 1, 2018
·
3 min read
Business

IDEXX Laboratories Announces Third Quarter 2018 Results

Reports revenue growth of 11% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic

November 1, 2018
·
31 min read
Business

Teleflex Reports Third Quarter 2018 Results

Third Quarter Revenues of $609.7 million, up 14.0% Versus Prior Year Period; up 15.0% on Constant Currency Basis

November 1, 2018
·
35 min read
Business

Eagle Pharmaceuticals, Inc. Reports Third Quarter 2018 Results

Q3 2018 net income was $0.94 per basic and $0.91 per diluted share and adjusted non-GAAP net income was $1.22 per basic and $1.18 per diluted share

November 1, 2018
·
19 min read
Deals

Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC

Milestone towards Completing Transaction to Establish Leadership in South American Market

November 1, 2018
·
10 min read
Policy

Spectrum Cannabis comments on UK cannabis framework

Spectrum Cannabis, a wholly-owned subsidiary of Canopy Growth Corporation (TSX: WEED)(NYSE: CGC), joins UK patients, researchers and clinicians in applauding today’s first prescriptions of medicinal cannabis.

November 1, 2018
·
7 min read